MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2017

Jul 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK: 0001157601
Period of Report: 2017-06-29

Reporting Person: Gollust Keith R (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-29	Stock Option (Right to Buy)	$16.46	A	10000	Acquired	2027-06-29	Common Stock (10000)	Direct

Footnotes

F1: The option vests 100% on the first anniversary of the date of grant, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.